⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNTB News
Connect Biopharma Holdings Limited Ordinary Shares
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
globenewswire.com
CNTB
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
CNTB
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
CNTB
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
CNTB
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight
prnewswire.com
AMGN
CNTB
NKTR
APGE
LLY
OGN
ABBV
PFE
REGN
INCY
House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English
prnewswire.com
ALKS
STG
GSK
SNY
TEVA
AZN
INCY
REGN
PFE
BMY
LLY
AMGN
ABBV
GILD
BIIB
CSL
VRTX
BHC
NVS
MRK
LEO
ALLT
CNTB
INM
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
globenewswire.com
CNTB
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
globenewswire.com
CNTB
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
accessnewswire.com
CNTB
Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
CNTB